MicroRNA-6852 suppresses glioma A172 cell proliferation and invasion by targeting LEF1

Area of Science:

• Neuro-oncology
• Molecular Biology
• Cancer Research

Background:

• microRNA (miR)-6852 is known to inhibit gastric, colorectal, and cervical cancers.
• The role of miR-6852 in regulating glioma cells remains unclear.
• Glioma is a primary brain tumor with significant mortality.

Purpose of the Study:

• To investigate the mechanism of miR-6852 in glioma progression.
• To determine the direct target of miR-6852 in glioma cells.
• To evaluate the therapeutic potential of miR-6852 in glioma.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) to assess miR-6852 expression in glioma tissues and cells.
• Cell Counting Kit-8 (CCK-8) and Transwell assays to evaluate cell proliferation, migration, and invasion.
• Western blotting and luciferase reporter assays to confirm the direct interaction between miR-6852 and lymphoid enhancer binding factor 1 (LEF1).

Main Results:

• miR-6852 expression was significantly downregulated in glioma tissues and cells compared to normal controls.
• Overexpression of miR-6852 in A172 glioma cells reduced proliferation, migration, and invasion.
• Inhibition of miR-6852 led to increased proliferation, migration, and invasion of A172 cells.
• LEF1 was identified as a direct target of miR-6852, with inverse correlation observed in glioma tissues.
• Restoration of LEF1 expression reversed the inhibitory effects of miR-6852 mimics on glioma cells.

Conclusions:

• miR-6852 acts as a tumor suppressor in glioma.
• The miR-6852/LEF1 axis plays a critical role in regulating glioma cell proliferation, migration, and invasion.
• miR-6852 may serve as a potential therapeutic target for glioma treatment.